MoonLake Immunotherapeutics
MLTX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821586
In the last 90 days, MoonLake Immunotherapeutics insiders filed 0 open-market purchases and 6 sales; 172 institutions reported holding it in 13F filings for Q2 2026, worth $1.43B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in MoonLake Immunotherapeutics as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 43
- +10 vs. Q4 2022
- Shares held
- 39.4M
- +1.67M (+4.4%) vs. Q4 2022
- Total value
- $843.2M
- +$446.8M (+112.7%) vs. Q4 2022
- New holders
- 21
- 11 more added
- Sold out
- 11
- 6 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MLTX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 172 | $1.43B |
| Q1 2026 | 147 | $1.17B |
| Q4 2025 | 130 | $742.9M |
| Q3 2025 | 134 | $269.7M |
| Q2 2025 | 130 | $2.77B |
| Q1 2025 | 136 | $2.34B |
| Q4 2024 | 116 | $3.43B |
| Q3 2024 | 109 | $3.14B |
| Q2 2024 | 111 | $2.67B |
| Q1 2024 | 114 | $2.99B |
| Q4 2023 | 125 | $3.53B |
| Q3 2023 | 118 | $3.21B |
| Q2 2023 | 83 | $2.86B |
| Q1 2023 | 43 | $843.2M |
| Q4 2022 | 33 | $396.4M |
| Q3 2022 | 24 | $291.4M |
| Q2 2022 | 23 | $190.1M |
| Q1 2022 | 27 | $123.4M |
| Q4 2021 | 45 | $112.8M |
| Q3 2021 | 43 | $111.1M |
| Q2 2021 | 46 | $115.8M |
| Q1 2021 | 42 | $108.9M |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding MoonLake Immunotherapeutics; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Advisor Group Holdings, Inc. | 76 | $1.62K | 0.00% | +76 | New |
| Royal Bank of Canada | 656 | $14.0K | 0.00% | +580+763.2% | Added |
| Dorsey Wright & Associates | 1,000 | $21.4K | 0.01% | +1,000 | New |
| UBS Group AG | 7,960 | $170.3K | 0.00% | −65,428−89.2% | Reduced |
| Bank of America Corp | 10,280 | $219.9K | 0.00% | +2,380+30.1% | Added |
| Ensign Peak Advisors, Inc | 11,575 | $247.6K | 0.00% | +11,575 | New |
| Boulder Hill Capital Management LP | 14,500 | $310.2K | 0.25% | +14,500 | New |
| SVB Financial Group | 16,173 | $345.9K | 0.66% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 17,109 | $366.0K | 0.00% | +5,658+49.4% | Added |
| Renaissance Technologies LLC | 22,700 | $486.0K | 0.00% | +11,091+95.5% | Added |
| Velan Capital Investment Management LP | 23,400 | $500.5K | 0.44% | +23,400 | New |
| Jane Street Group, LLC | 26,034 | $556.9K | 0.00% | +26,034 | New |
| Point72 Asset Management, L.P. | 29,748 | $636.3K | 0.00% | +29,748 | New |
| Morgan Stanley | 32,519 | $695.6K | 0.00% | +5,154+18.8% | Added |
| Millennium Management LLC | 35,071 | $750.0K | 0.00% | +35,071 | New |
| Schonfeld Strategic Advisors LLC | 37,200 | $795.7K | 0.01% | +37,200 | New |
| 5AM Venture Management, LLC | 38,856 | $831.1K | 0.21% | +38,856 | New |
| Manufacturers Life Insurance Company, The | 48,550 | $1.04M | 0.00% | +48,550 | New |
| Cubist Systematic Strategies, LLC | 59,858 | $1.28M | 0.01% | +59,858 | New |
| TD Asset Management Inc | 67,312 | $1.44M | 0.00% | 00.0% | Unchanged |
| Jefferies Financial Group Inc. | 69,713 | $1.49M | 0.03% | +2,059+3.0% | Added |
| Ally Bridge Group (NY) LLC | 72,850 | $1.56M | 2.04% | +72,850 | New |
| Granahan Investment Management Inc | 73,637 | $1.58M | 0.05% | +73,637 | New |
| Citigroup Inc | 77,276 | $1.65M | 0.00% | −89,041−53.5% | Reduced |
| Silverarc Capital Management, LLC | 105,750 | $2.26M | 1.02% | +105,750 | New |
| Fred Alger Management, LLC | 106,920 | $2.29M | 0.01% | +106,920 | New |
| BlackRock Inc. | 114,930 | $2.46M | 0.00% | −626,828−84.5% | Reduced |
| HighVista Strategies LLC | 122,201 | $2.61M | 2.13% | +122,201 | New |
| Invesco Ltd. | 176,770 | $3.78M | 0.00% | +176,770 | New |
| Ghost Tree Capital, LLC | 195,000 | $4.17M | 1.58% | +195,000 | New |
| Balyasny Asset Management LLC | 197,707 | $4.23M | 0.01% | −20,292−9.3% | Reduced |
| Great Point Partners LLC | 278,334 | $5.95M | 1.18% | −364,232−56.7% | Reduced |
| AXA S.A. | 301,354 | $6.45M | 0.02% | −103,930−25.6% | Reduced |
| JPMorgan Chase & Co | 303,222 | $6.49M | 0.00% | +258,378+576.2% | Added |
| FMR LLC | 475,432 | $10.2M | 0.00% | +289,932+156.3% | Added |
| RTW Investments, LP | 500,000 | $10.7M | 0.22% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 804,499 | $17.2M | 0.04% | +804,499 | New |
| Price T Rowe Associates Inc | 830,906 | $17.8M | 0.00% | +8,305+1.0% | Added |
| Polar Capital Holdings Plc | 876,377 | $18.7M | 0.14% | 00.0% | Unchanged |
| Adage Capital Partners GP, L.L.C. | 1,668,871 | $35.7M | 0.08% | +1,668,871 | New |
| Citadel Advisors LLC | 2,923,438 | $62.5M | 0.07% | +37,346+1.3% | Added |
| Cormorant Asset Management, LP | 6,892,101 | $147.4M | 9.71% | +827,100+13.6% | Added |
| BVF Inc | 21,751,284 | $465.3M | 17.01% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 0 | $0 | 0.00% | −1,000,000−100.0% | Sold out |
| Braidwell LP | 0 | $0 | 0.00% | −381,120−100.0% | Sold out |
| Tekla Capital Management LLC | 0 | $0 | 0.00% | −300,000−100.0% | Sold out |
| Tang Capital Management LLC | 0 | $0 | 0.00% | −245,714−100.0% | Sold out |
| Acuta Capital Partners, LLC | 0 | $0 | 0.00% | −93,500−100.0% | Sold out |
| Barclays PLC | 0 | $0 | 0.00% | −55,952−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −32,129−100.0% | Sold out |
| Meridian Wealth Management, LLC | 0 | $0 | 0.00% | −15,000−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −14,395−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −12,385−100.0% | Sold out |
| Goldman Sachs Group Inc | 0 | $0 | 0.00% | −10,110−100.0% | Sold out |